|$112,120||To develop a white paper outlining issues that are key for the succesful distribution of a COVID-19 vaccine.||2020 - 2021||LJAF|
|$74,497||To create an evidence-base to support the policy debate related to high prescription drug pricing.||2019 - 2020||LJAF|
|$207,774||To (i) research and analyze anticompetitive behaviors impacting prescription drug pricing, and (ii) provide nonpartisan information and technical support to key stakeholders and policymakers.||2019 - 2020||LJAF|
|$248,354||To inform ongoing investigations into pharmaceutical industry pricing practices.||2020 - 2021||LJAF|
|$503,352||To provide nonpartisan information and technical support to key stakeholders regarding prescription drug policy and publicly disseminate educational resources.||2018 - 2019||LJAF|
|$903,466||To provide information and technical support to help policymakers lower health care costs.||2019 - 2021||LJAF|
Have an evidence-based week
Get The Abstract from Arnold Ventures delivered to your inbox.